← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV18행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
AntibodyPhase 2
Simvastatin (Simvastatin)
Organon and Co·Lymphoma
63 trials
Overview
Program
Simvastatin
Overview
Company
Organon and Co
Overview
Modality
ANTIBODY
Overview
Target
Lymphoma
Overview
Indication
Colorectal Cancer
Overview
Phase
PHASE_2
Overview
Status
RECRUITING
MoA
Mechanism
blocks bacterial invasion by targeting key host factors, including collagen I (using FT011), lipid rafts (using simvastatin), integrin β1 (using ATN-161), and FAK signaling
MoA
Biomarker
biomarkers
PK/PD
Species
Rat, carbamazepine, cyclosporine, and quinidine.
PK/PD
Animal (cat.)
Rat
PK/PD
Experiment
PD
Toxicology
Species
Rat, carbamazepine, cyclosporine, and quinidine.
Toxicology
Animal (cat.)
Rat
Toxicology
Major finding
Role of CXCL16/ADAM10 signaling in methotrexate-induced nephrotoxicity and its modulation by simvastatin.. Methotrexate (MTX) is a widely used chemotherapeutic and immunosuppressive agent; however, one of clinical limitations of its use is renal toxicity. CXCL16 is a transmembrane chemokine that can be cleaved by ADAM family proteases, particularly ADAM10, to generate a soluble form that acts as a…
Clinical
Data Tier / Score
A · 34
Clinical
Program phase
PHASE_2
Clinical
Clinical sync
2026년 7월 12일 (2일 전)